TSX:VMD

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Viemed Healthcare

Executive Summary

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and health care solutions to patients in the United States. More Details


Snowflake Analysis

Flawless balance sheet with solid track record.

Share Price & News

How has Viemed Healthcare's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: VMD is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: VMD's weekly volatility (8%) has been stable over the past year.


Market Performance


7 Day Return

5.3%

VMD

-0.6%

CA Healthcare

1.7%

CA Market


1 Year Return

45.8%

VMD

4.8%

CA Healthcare

0.2%

CA Market

Return vs Industry: VMD exceeded the Canadian Healthcare industry which returned 4.8% over the past year.

Return vs Market: VMD exceeded the Canadian Market which returned 0.2% over the past year.


Shareholder returns

VMDIndustryMarket
7 Day5.3%-0.6%1.7%
30 Day-5.2%1.1%7.0%
90 Day-18.7%9.4%5.1%
1 Year45.8%45.8%9.6%4.8%3.9%0.2%
3 Yearn/a9.6%-5.9%13.1%2.1%
5 Yearn/a1.6%-19.8%46.5%24.1%

Long-Term Price Volatility Vs. Market

How volatile is Viemed Healthcare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Viemed Healthcare undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: VMD (CA$11.85) is trading below our estimate of fair value (CA$40.71)

Significantly Below Fair Value: VMD is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: VMD is good value based on its PE Ratio (12.1x) compared to the CA Healthcare industry average (32x).

PE vs Market: VMD is good value based on its PE Ratio (12.1x) compared to the Canadian market (15.3x).


Price to Earnings Growth Ratio

PEG Ratio: VMD's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: VMD is overvalued based on its PB Ratio (4.7x) compared to the CA Healthcare industry average (2.8x).


Next Steps

Future Growth

How is Viemed Healthcare forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

-41.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: VMD's earnings are forecast to decline over the next 3 years (-41.8% per year).

Earnings vs Market: VMD's earnings are forecast to decline over the next 3 years (-41.8% per year).

High Growth Earnings: VMD's earnings are forecast to decline over the next 3 years.

Revenue vs Market: VMD's revenue is expected to decline over the next 3 years (-2.5% per year).

High Growth Revenue: VMD's revenue is forecast to decline over the next 3 years (-2.5% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if VMD's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Viemed Healthcare performed over the past 5 years?

29.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: VMD has a large one-off gain of $6.1M impacting its September 30 2020 financial results.

Growing Profit Margin: VMD's current net profit margins (23.7%) are higher than last year (11.1%).


Past Earnings Growth Analysis

Earnings Trend: VMD's earnings have grown significantly by 29.6% per year over the past 5 years.

Accelerating Growth: VMD's earnings growth over the past year (238.8%) exceeds its 5-year average (29.6% per year).

Earnings vs Industry: VMD earnings growth over the past year (238.8%) exceeded the Healthcare industry 15.9%.


Return on Equity

High ROE: VMD's Return on Equity (38.4%) is considered high.


Next Steps

Financial Health

How is Viemed Healthcare's financial position?


Financial Position Analysis

Short Term Liabilities: VMD's short term assets ($50.0M) exceed its short term liabilities ($30.3M).

Long Term Liabilities: VMD's short term assets ($50.0M) exceed its long term liabilities ($8.4M).


Debt to Equity History and Analysis

Debt Level: VMD's debt to equity ratio (11.4%) is considered satisfactory.

Reducing Debt: VMD's debt to equity ratio has reduced from 26.7% to 11.4% over the past 5 years.

Debt Coverage: VMD's debt is well covered by operating cash flow (428.2%).

Interest Coverage: VMD's interest payments on its debt are well covered by EBIT (29.2x coverage).


Balance Sheet


Next Steps

Dividend

What is Viemed Healthcare current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate VMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if VMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VMD's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of VMD's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.9yrs

Average management tenure


CEO

Casey Hoyt (43 yo)

2.92yrs

Tenure

US$2,167,644

Compensation

Mr. Casey Hoyt has been Director of Viemed Healthcare, Inc. since December 14, 2016 and serves as Chief Executive Officer. Mr. Hoyt served as Chief Executive Officer of Patient Home Monitoring Corp. from ...


CEO Compensation Analysis

Compensation vs Market: Casey's total compensation ($USD2.17M) is above average for companies of similar size in the Canadian market ($USD864.82K).

Compensation vs Earnings: Casey's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Casey Hoyt
CEO & Director2.92yrsUS$2.17m5.3%
$ 24.8m
Michael Moore
President2.92yrsUS$1.73m4.44%
$ 20.8m
Trae Fitzgerald
Chief Financial Officer2.92yrsUS$677.33k0.088%
$ 412.2k
William Zehnder
COO & Director2.92yrsUS$1.68m0.29%
$ 1.4m
Jerome Cambre
Vice President of Sales2.67yrsUS$657.93k0.11%
$ 525.8k
William Frazier
Chief Medical Officer & Director2.92yrsno data0.070%
$ 329.4k
John Collier
Chief Technology Officer0.92yrno datano data
Claudio Munoz
Chief Information Officer0.92yrno datano data
Brett Stoute
Chief Compliance Officerno datano datano data
Rob Birkhead
Chief Marketing Officer0.92yrno datano data
Chris Weeks
Vice President of Human Resources0.92yrno datano data
Ryan Sullivan
Executive Vice President0.92yrno datano data

0.9yrs

Average Tenure

44yo

Average Age

Experienced Management: VMD's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Casey Hoyt
CEO & Director2.92yrsUS$2.17m5.3%
$ 24.8m
William Zehnder
COO & Director2.92yrsUS$1.68m0.29%
$ 1.4m
William Frazier
Chief Medical Officer & Director2.92yrsno data0.070%
$ 329.4k
Randolph Dobbs
Independent Chairman2.92yrsUS$162.93k0.14%
$ 646.5k
Nitin Kaushal
Independent Director2.92yrsUS$162.93k0.21%
$ 972.0k
Sabrina Heltz
Independent Directorno datano datano data
Timothy Smokoff
Independent Director2.83yrsUS$162.93k0.12%
$ 550.8k
Bruce Greenstein
Independent Director2.33yrsUS$162.93k0.079%
$ 371.2k

2.9yrs

Average Tenure

54yo

Average Age

Experienced Board: VMD's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: VMD insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.1%.


Top Shareholders

Company Information

Viemed Healthcare, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Viemed Healthcare, Inc.
  • Ticker: VMD
  • Exchange: TSX
  • Founded: 2006
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$468.568m
  • Shares outstanding: 39.15m
  • Website: https://www.viemed.com

Number of Employees


Location

  • Viemed Healthcare, Inc.
  • 625 East Kaliste Saloom Road
  • Lafayette
  • Louisiana
  • 70508
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VMDTSX (The Toronto Stock Exchange)YesCommon SharesCACADDec 2017
VMDNasdaqCM (Nasdaq Capital Market)YesCommon SharesUSUSDDec 2017
VIJDB (Deutsche Boerse AG)YesCommon SharesDEEURDec 2017

Biography

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and health care solutions to patients in the United States. The company offers respiratory services and related...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/25 00:10
End of Day Share Price2020/11/24 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.